Associated Genetic Biomarkers

Overview

Gene Location [1]
19q13.2
Variant Type
Amplification
Gene
AXL

AXL Amplification is present in 0.21% of AACR GENIE cases, with lung adenocarcinoma, breast invasive ductal carcinoma, squamous cell lung carcinoma, high grade ovarian serous adenocarcinoma, and pancreatic adenocarcinoma having the greatest prevalence [4].

Top Disease Cases with AXL Amplification

Significance of AXL Amplification in Diseases

Malignant Solid Tumor +

Non-Small Cell Lung Carcinoma +

Osteosarcoma +

Adrenal Cortex Carcinoma +

Soft Tissue Sarcoma +

Rhabdomyosarcoma +

Cancer +

Head And Neck Squamous Cell Carcinoma +

Alveolar Soft Part Sarcoma +

Clear Cell Sarcoma Of Soft Tissue +

Ewing Sarcoma +

Hepatoblastoma +

Hepatocellular Carcinoma +

Renal Cell Carcinoma +

Thyroid Gland Medullary Carcinoma +

Wilms Tumor +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.